CRVOCervoMed Inc.
- Market cap
- $34.93M
- as of 2026-10-23
- Latest close
- $2.31
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-09
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Blackburn KellyEVP, Clinical Development | Oct 22 | Oct 23 | A · derivative | 19,100 | $2.24 | $42,784 | 19,100 | No | Form 4 |
| De Rosch MarkEVP, RA and GA and PgM | Oct 22 | Oct 23 | A · derivative | 19,100 | $2.24 | $42,784 | 19,100 | No | Form 4 |
| Winton MatthewChief Commercial and Business | Oct 22 | Oct 23 | A · derivative | 19,100 | $2.24 | $42,784 | 19,100 | No | Form 4 |
| Boger Joshua S | Jun 11 | Jun 15 | P | 955,414 | $3.14 | Purchase +$3,000,000 | 1,795,865 | No | Form 4 |
| Boger Joshua S | Jun 11 | Jun 15 | P · derivative | 955,414 | $3.32 | Purchase +$3,171,974 | 955,414 | No | Form 4 |
| Boger Joshua S | Jun 11 | Jun 15 | P · derivative | 955,414 | $3.14 | Purchase +$3,000,000 | 955,414 | No | Form 4 |
| Alam John JCEO & President | Jun 8 | Jun 10 | A · derivative | 8,150 | $2.91 | $23,717 | 8,150 | No | Form 4 |
| Boger Joshua S | Jun 8 | Jun 10 | A · derivative | 8,150 | $2.91 | $23,717 | 8,150 | No | Form 4 |
| Gregoire Sylvie | Jun 8 | Jun 10 | A · derivative | 8,150 | $2.91 | $23,717 | 8,150 | No | Form 4 |
| Hollingsworth Jane H | Jun 8 | Jun 10 | A · derivative | 8,150 | $2.91 | $23,717 | 8,150 | No | Form 4 |
| Poulton Jeffrey V. | Jun 8 | Jun 10 | A · derivative | 8,150 | $2.91 | $23,717 | 8,150 | No | Form 4 |
| Quigley David | Jun 8 | Jun 10 | A · derivative | 8,150 | $2.91 | $23,717 | 8,150 | No | Form 4 |
| Sabbagh Marwan | Jun 8 | Jun 10 | A · derivative | 8,150 | $2.91 | $23,717 | 8,150 | No | Form 4 |
| Zavrl Frank | Jun 8 | Jun 10 | A · derivative | 8,150 | $2.91 | $23,717 | 8,150 | No | Form 4 |
| Alam John JCEO & President | Feb 11 | Feb 13 | A · derivative | 75,000 | $4.80 | $360,000 | 75,000 | No | Form 4 |
| Blackburn KellyEVP, Clinical Development | Feb 11 | Feb 13 | A · derivative | 30,000 | $4.80 | $144,000 | 30,000 | No | Form 4 |
| De Rosch MarkEVP, RA and GA and PgM | Feb 11 | Feb 13 | A · derivative | 30,000 | $4.80 | $144,000 | 30,000 | No | Form 4 |
| Elder William RobertCFO, GC & Secretary | Feb 11 | Feb 13 | A · derivative | 30,000 | $4.80 | $144,000 | 30,000 | No | Form 4 |
| Gregoire Sylvie | Feb 11 | Feb 13 | A · derivative | 75,000 | $4.80 | $360,000 | 75,000 | No | Form 4 |
| Winton MatthewChief Commercial and Business | Feb 11 | Feb 13 | A · derivative | 30,000 | $4.80 | $144,000 | 30,000 | No | Form 4 |
| Quigley David | Oct 27, 2025 | Dec 5, 2025 | A · derivative | 16,200 | $7.02 | $113,724 | 16,200 | No | Form 4 |
| Elder William RobertCFO, GC & Secretary | Nov 18, 2025 | Nov 19, 2025 | P | 2,500 | $8.32 | Purchase +$20,800 | 12,500 | No | Form 4 |
| Winton MatthewChief Commercial and Business | Nov 18, 2025 | Nov 19, 2025 | P | 1,500 | $7.95 | Purchase +$11,925 | 15,000 | No | Form 4 |
| Alam John JCEO & President | Nov 17, 2025 | Nov 19, 2025 | P | 10,807 | $8.46 | Purchase +$91,427 | 1,484,078 | No | Form 4 |
| Alam John JCEO & President | Nov 17, 2025 | Nov 19, 2025 | P | 10,793 | $8.46 | Purchase +$91,309 | 12,500 | No | Form 4 |
| Elder William RobertCFO, GC & Secretary | Nov 17, 2025 | Nov 19, 2025 | P | 1,000 | $8.45 | Purchase +$8,450 | 10,000 | No | Form 4 |
| Gregoire Sylvie | Nov 17, 2025 | Nov 19, 2025 | P | 10,793 | $8.46 | Purchase +$91,309 | 1,484,078 | No | Form 4 |
| Gregoire Sylvie | Nov 17, 2025 | Nov 19, 2025 | P | 10,807 | $8.46 | Purchase +$91,427 | 12,500 | No | Form 4 |
| Winton MatthewChief Commercial and Business | Nov 17, 2025 | Nov 19, 2025 | P | 3,500 | $8.43 | Purchase +$29,505 | 13,500 | No | Form 4 |
| Winton MatthewChief Commercial and Business | Nov 14, 2025 | Nov 17, 2025 | P | 10,000 | $7.57 | Purchase +$75,700 | 10,000 | No | Form 4 |
| Alam John JCEO & President | Nov 14, 2025 | Nov 17, 2025 | P | 1,693 | $7.55 | Purchase +$12,782 | 1,473,271 | No | Form 4 |
| Alam John JCEO & President | Nov 14, 2025 | Nov 17, 2025 | P | 1,707 | $7.57 | Purchase +$12,922 | 1,707 | No | Form 4 |
| Gregoire Sylvie | Nov 14, 2025 | Nov 17, 2025 | P | 1,707 | $7.57 | Purchase +$12,922 | 1,473,285 | No | Form 4 |
| Gregoire Sylvie | Nov 14, 2025 | Nov 17, 2025 | P | 1,693 | $7.55 | Purchase +$12,782 | 1,693 | No | Form 4 |
| Alam John JCEO & President | Nov 13, 2025 | Nov 17, 2025 | P | 4,447 | $7.51 | Purchase +$33,397 | 1,471,578 | No | Form 4 |
| Gregoire Sylvie | Nov 13, 2025 | Nov 17, 2025 | P | 4,447 | $7.51 | Purchase +$33,397 | 1,471,578 | No | Form 4 |
| Alam John JCEO & President | Nov 12, 2025 | Nov 13, 2025 | P | 5,553 | $7.35 | Purchase +$40,815 | 1,467,131 | No | Form 4 |
| Elder William RobertCFO, GC & Secretary | Nov 12, 2025 | Nov 13, 2025 | P | 3,500 | $7.44 | Purchase +$26,040 | 9,000 | No | Form 4 |
| Gregoire Sylvie | Nov 12, 2025 | Nov 13, 2025 | P | 5,553 | $7.35 | Purchase +$40,815 | 1,467,131 | No | Form 4 |
| Winton MatthewChief Commercial and Business | Oct 6, 2025 | Oct 8, 2025 | A · derivative | 75,000 | $8.62 | $646,500 | 75,000 | No | Form 4 |
| Gregoire Sylvie | Jun 23, 2025 | Jun 25, 2025 | A · derivative | 8,100 | $6.52 | $52,812 | 8,100 | No | Form 4 |
| Hollingsworth Jane H | Jun 23, 2025 | Jun 25, 2025 | A · derivative | 8,100 | $6.52 | $52,812 | 8,100 | No | Form 4 |
| Poulton Jeffrey V. | Jun 23, 2025 | Jun 25, 2025 | A · derivative | 8,100 | $6.52 | $52,812 | 8,100 | No | Form 4 |
| Sabbagh Marwan | Jun 23, 2025 | Jun 25, 2025 | A · derivative | 8,100 | $6.52 | $52,812 | 8,100 | No | Form 4 |
| Boger Joshua S | Jun 23, 2025 | Jun 25, 2025 | A · derivative | 8,100 | $6.52 | $52,812 | 8,100 | No | Form 4 |
| Zavrl Frank | Jun 23, 2025 | Jun 25, 2025 | A · derivative | 8,100 | $6.52 | $52,812 | 8,100 | No | Form 4 |
| Alam John JCEO & President | Jun 23, 2025 | Jun 25, 2025 | A · derivative | 8,100 | $6.52 | $52,812 | 8,100 | No | Form 4 |
| Elder William RobertCFO, GC & Secretary | May 14, 2025 | May 14, 2025 | P | 4,233 | $8.46 | Purchase +$35,811 | 5,500 | No | Form 4 |
| Alam John JCEO & President | Feb 4, 2025 | Feb 14, 2025 | A · derivative | 60,000 | $2.30 | $138,000 | 60,000 | No | Form 4 |
| Blackburn KellySVP, Clinical Development | Feb 4, 2025 | Feb 14, 2025 | A · derivative | 27,000 | $2.30 | $62,100 | 27,000 | No | Form 4 |
| Cobuzzi Robert Joseph Jr.Chief Operating Officer | Feb 4, 2025 | Feb 14, 2025 | A · derivative | 27,000 | $2.30 | $62,100 | 27,000 | No | Form 4 |
| Elder William RobertCFO & GC | Feb 4, 2025 | Feb 14, 2025 | A · derivative | 27,000 | $2.30 | $62,100 | 27,000 | No | Form 4 |
| Gregoire Sylvie | Feb 4, 2025 | Feb 14, 2025 | A · derivative | 60,000 | $2.30 | $138,000 | 60,000 | No | Form 4 |
| Elder William RobertCFO & GC | Aug 27, 2024 | Aug 27, 2024 | P | 1,000 | $18.16 | Purchase +$18,160 | 1,267 | No | Form 4 |
| Zavrl Frank | Jun 14, 2024 | Jun 14, 2024 | A · derivative | 5,750 | $19.01 | $109,308 | 5,750 | No | Form 4 |
| Sabbagh Marwan | Jun 14, 2024 | Jun 14, 2024 | A · derivative | 5,750 | $19.01 | $109,308 | 5,750 | No | Form 4 |
| Poulton Jeffrey V. | Jun 14, 2024 | Jun 14, 2024 | A · derivative | 5,750 | $19.01 | $109,308 | 5,750 | No | Form 4 |
| Hollingsworth Jane H | Jun 14, 2024 | Jun 14, 2024 | A · derivative | 5,750 | $19.01 | $109,308 | 5,750 | No | Form 4 |
| Gregoire Sylvie | Jun 14, 2024 | Jun 14, 2024 | A · derivative | 5,750 | $19.01 | $109,308 | 5,750 | No | Form 4 |
| Boger Joshua S | Jun 14, 2024 | Jun 14, 2024 | A · derivative | 5,750 | $19.01 | $109,308 | 5,750 | No | Form 4 |
| Alam John JCEO & President | Jun 14, 2024 | Jun 14, 2024 | A · derivative | 5,750 | $19.01 | $109,308 | 5,750 | No | Form 4 |
| Boger Joshua S | Feb 26, 2024 | Feb 28, 2024 | X | 495,995 | not reported | not reported | 840,487 | No | Form 4 |
| Boger Joshua S | Feb 26, 2024 | Feb 28, 2024 | S | 36 | not reported | Sale not reported | 840,451 | No | Form 4 |
| Boger Joshua S | Feb 26, 2024 | Feb 28, 2024 | X · derivative | 495,995 | not reported | not reported | not reported | No | Form 4 |
| Boger Joshua S | Feb 12, 2024 | Feb 13, 2024 | A · derivative | 10,000 | $13.97 | $139,700 | 10,000 | No | Form 4 |
| Cobuzzi Robert Joseph Jr.Chief Operating Officer | Jan 26, 2024 | Jan 26, 2024 | A · derivative | 55,721 | $9.05 | $504,275 | 55,721 | No | Form 4 |
| Gregoire Sylvie | Jan 26, 2024 | Jan 26, 2024 | A · derivative | 35,500 | $9.05 | $321,275 | 35,500 | No | Form 4 |
| Elder William RobertGC & Secretary | Jan 26, 2024 | Jan 26, 2024 | A · derivative | 16,000 | $9.05 | $144,800 | 16,000 | No | Form 4 |
| Tanner John WilliamChief Financial Officer | Jan 26, 2024 | Jan 26, 2024 | A · derivative | 16,000 | $9.05 | $144,800 | 16,000 | No | Form 4 |
| Blackburn KellySVP, Clinical Development | Jan 26, 2024 | Jan 26, 2024 | A · derivative | 16,000 | $9.05 | $144,800 | 16,000 | No | Form 4 |
| Alam John JCEO & President | Jan 26, 2024 | Jan 26, 2024 | A · derivative | 35,500 | $9.05 | $321,275 | 35,500 | No | Form 4 |
| Tanner John WilliamChief Financial Officer | Nov 20, 2023 | Nov 22, 2023 | A · derivative | 32,000 | $9.82 | $314,240 | 32,000 | No | Form 4 |
| Alam John JCEO & President | Nov 9, 2023 | Nov 9, 2023 | G | 12,500 | $0.00 | $0 | 729,539 | No | Form 4 |
| Gregoire Sylvie | Nov 9, 2023 | Nov 9, 2023 | G | 10,000 | $0.00 | $0 | 732,039 | No | Form 4 |